| __timestamp | Geron Corporation | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8901000 | 205018000 |
| Thursday, January 1, 2015 | 9574000 | 392709000 |
| Friday, January 1, 2016 | 14695000 | 299694000 |
| Sunday, January 1, 2017 | 8437000 | 397061000 |
| Monday, January 1, 2018 | 12723000 | 434100000 |
| Tuesday, January 1, 2019 | 51272000 | 782200000 |
| Wednesday, January 1, 2020 | 50052000 | 1119900000 |
| Friday, January 1, 2021 | 783000 | 2437500000 |
| Saturday, January 1, 2022 | 868000 | 1560400000 |
| Sunday, January 1, 2023 | 123740000 | 1815800000 |
| Monday, January 1, 2024 | 1970500000 |
Infusing magic into the data realm
In the competitive world of biotechnology, cost efficiency is a critical factor for success. This analysis compares the cost of revenue efficiency between Regeneron Pharmaceuticals, Inc. and Geron Corporation from 2014 to 2023. Over this period, Regeneron consistently outperformed Geron, with its cost of revenue peaking at approximately $1.8 billion in 2023, a staggering 1,370% increase from 2014. In contrast, Geron's cost of revenue showed a more volatile trend, culminating in a peak of around $123 million in 2023, a 1,284% increase from its 2014 figure. This stark contrast highlights Regeneron's robust growth and operational efficiency, while Geron faced more fluctuations. The data underscores the importance of strategic financial management in sustaining growth and competitiveness in the biotech sector.
Cost Insights: Breaking Down Novo Nordisk A/S and Geron Corporation's Expenses
Cost of Revenue: Key Insights for AbbVie Inc. and Geron Corporation
Analyzing Cost of Revenue: Novartis AG and Geron Corporation
Cost Insights: Breaking Down Amgen Inc. and Regeneron Pharmaceuticals, Inc.'s Expenses
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Geron Corporation's Expenses
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Biogen Inc.'s Expenses
Regeneron Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Comparing Cost of Revenue Efficiency: Viatris Inc. vs Geron Corporation
Agios Pharmaceuticals, Inc. vs Geron Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Geron Corporation vs Iovance Biotherapeutics, Inc.
Analyzing Cost of Revenue: Geron Corporation and Wave Life Sciences Ltd.